Skip to main content
. 2012 Jan 30;7(1):e30525. doi: 10.1371/journal.pone.0030525

Table 2. The levels of chemokines in cerebrospinal fluid (CSF) and plasma obtained at baseline.

CSF Controls n = 30 Stable MCI n = 52 MCI-AD n = 47 MCI-other n = 20
CCL2 649±182 676±183 684±194 729±176
CCL11 11±4 12±4 12±5 12±5
CCL13 14±10 12±10 16±13 20±29
CCL26 14±19 33±55 33±48a 16±20

The chemokine levels are given in pg/ml. Only P-values<0.01 are considered significant, because of correction for multiple comparisons (all groups were compared to both controls and stable MCI).

a

P<0.01 vs Controls.

b

P<0.01 vs Stable MCI.

Abbreviations: Stable MCI, patients with MCI with stable cognitive functions during a follow-up period of 5.2 years; MCI-AD, patients with MCI who developed Alzheimer's disease during follow-up; MCI-other, patients with MCI who developed other types of dementia during follow-up; CSF, cerebrospinal fluid.